Brera's Boardroom Battle: A Win Secured by Self-Issued Shares?

NEW YORK, NY – June 29, 2026 – A bitter corporate governance battle has erupted at Brera Holdings PLC (d/b/a Solmate Infrastructure), a Nasdaq-listed company pivotal to the Solana blockchain ecosystem. The company celebrated a “decisive” re-election of its entire board at its recent Annual General Meeting (AGM). However, its largest external shareholder, RBCH Ltd., paints a starkly different picture—one of a board surviving not by shareholder endorsement, but by voting millions of shares it had awarded to itself just weeks earlier at a steep discount.

The dispute pits Brera’s leadership against RBCH, an investment vehicle of the digital asset giant RockawayX and a holder of over 10% of the company. The allegations of self-dealing and board entrenchment have now escalated from proxy-fight rhetoric to a full-blown legal war, casting a shadow over a company tasked with building institutional-grade infrastructure for the high-speed Solana network.

A Victory Decided in the Boardroom, Not by Shareholders?

Brera Holdings announced on June 26 that all five of its director nominees were re-elected with what it termed decisive support, ranging from 62% to nearly 70% of shares voted. This public declaration of victory, however, was immediately challenged by RBCH, which presented arithmetic suggesting a shareholder rebellion was quashed only by a controversial share issuance.

According to RBCH, if one excludes the contested shares, the outcome flips dramatically. The activist shareholder alleges that approximately 3.0 million independent shares voted against the re-election of four directors—Ron Sade, Keren Maimon, Alyazi Saeed Ahmad Alkhattal Almeheiri, and Tariq Salem Ebraheem Alsaman Alnuaimi—while only 2.6 million voted in favor. Under this calculation, only one director, Erez Simha, would have retained his seat based on the will of external shareholders.

“Independent shareholders voted this board out,” a spokesperson for RBCH Ltd. stated. “Brera's characterization that this vote is a 'decisive victory' is difficult to reconcile with the arithmetic.”

Adding significant weight to the governance concerns, Institutional Shareholder Services (ISS), a leading independent proxy advisory firm, had recommended that shareholders vote against all five director nominees. ISS cited a litany of issues, including a lack of board independence, the absence of key governance committees, and the recent adoption of a “poison pill” rights agreement that it viewed as an entrenchment mechanism rather than a tool for shareholder protection.

The $11.4 Million Deal at the Heart of the Dispute

The crux of the conflict is a Registered Direct Offering (RDO) that closed on May 27, 2026. Through this deal, Brera issued 2,298,000 new shares exclusively to two of its own directors: Ron Sade, who had just been appointed CEO weeks earlier, and Keren Maimon. The timing was critical, closing just three business days before the June 1 record date, thereby making the newly minted shares eligible to be voted at the AGM.

What truly drew shareholder fire was the price. The shares were issued at $4.97 each, a figure RBCH claims represents a staggering 65% discount to the company’s reported net asset value of $14.70 per share. RBCH alleges this transaction, which diluted existing shareholders, was executed without a competitive process, an independent fairness opinion, or an opportunity for other investors to participate.

This maneuver, an operational tactic enabling insiders to bolster their own voting power ahead of a contentious election, is precisely what critics point to as a failure of fiduciary duty. As the RBCH spokesperson bluntly put it, “When a board survives re-election only by counting shares it awarded to itself weeks before the meeting, that is not an endorsement. That is entrenchment.”

From Shareholder Activism to Courtroom Warfare

The dispute has moved well beyond press releases. On June 22, RBCH filed a derivative lawsuit in the Supreme Court of the State of New York, accusing Brera’s directors of breach of fiduciary duty, shareholder oppression, and self-dealing. The lawsuit’s allegations extend beyond the RDO, painting a pattern of conflicted transactions. These include warrants representing over 15% of the company's equity granted to four insiders under a “Strategic Advisor Agreement” for which RBCH claims no services were documented, and a $6 million advisory agreement awarded to a firm whose principals include company directors.

Brera has fired back, not by addressing the specifics of the derivative suit, but by launching its own legal offensive. The company filed a lawsuit in Delaware against RockawayX CEO Viktor Fischer (who sat on Brera’s board until April), accusing him of orchestrating a “fraudulent campaign” and attempting a $200 million acquisition based on misleading financials. Brera’s CEO, Ron Sade, characterized RBCH’s lawsuit as a “meritless and tactical attempt to further distract the Company” and a retaliatory move for Brera’s own legal action.

This tit-for-tat litigation reveals a deeply fractured relationship and suggests a prolonged and costly battle ahead, distracting management and consuming resources that could otherwise be deployed to grow the business.

A Cloud Over Solmate's Solana Strategy

Beyond the boardroom theatrics and legal filings lies a critical strategic question about the future of Solmate Infrastructure. The company's mission is to build institutional-grade staking, validation, and treasury services on the Solana blockchain—an ecosystem predicated on principles of decentralization and trust. RockawayX, RBCH's parent, is one of Solana's earliest and most significant backers, operating its own extensive infrastructure.

The conflict creates a significant operational drag. Such high-profile infighting can deter potential institutional partners who demand stability and impeccable governance from their infrastructure providers. For a company whose very business is providing a foundation of trust for a digital economy, a public battle over its own integrity is profoundly damaging.

The core of the Nelson Report is identifying the operational innovations that drive success. In this case, the market is watching an alleged operational maneuver designed not for growth, but for control. As RBCH continues to pursue its claims in court, the ultimate arbiter may not be the board or even shareholders, but a judge who will be asked to define the line between a decisive victory and an act of entrenchment.